My MediHealth: A Paradigm for Children-centered Medication Management (mymedihealth)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01730235|
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : November 21, 2012
|Condition or disease||Intervention/treatment|
|Asthma||Other: MyMediHealth access|
|Study Type :||Observational|
|Actual Enrollment :||115 participants|
|Observational Model:||Case Control|
|Official Title:||My MediHealth: A Paradigm for Children-centered Medication Management|
|Study Start Date :||May 2012|
|Actual Primary Completion Date :||October 2012|
Group receiving access to MyMediHealth web site.
Children completing baseline and week two measures, but without any additional intervention.
Other: MyMediHealth access
Patients who will be given access to a web-based medication scheduling and SMS-based reminder system.
- Change in baseline asthma self efficacy after 3 weeks [ Time Frame: participants will be followed for an average of 4 weeks, with this measure collect at the beginning of the period and after 3 weeks of reminders. ]Will assess self-efficacy using the survey by Bursch and colleagues (1997)
- Change in medication adherence after 3 weeks [ Time Frame: Participants will be followed for 4 weeks, with measurements at baseline and the end of 3 weeks ]At the end of the 2-week data collection period (following the 1-week test period), all participants (Control and Intervention) and their parents will be asked to complete a brief online survey, including the Asthma Control Test (ACT) and the weekly adherence survey(SDSCA). All responses collected from participants and their parents in the Time 2 Survey will be compared to those collected from the Baseline Survey, where applicable. Medication adherence will be measured by responses to ACT and SDSCA survey items for all participants.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01730235
|United States, Tennessee|
|Vandebilt Monroe Carell Children's Hospital|
|Nashville, Tennessee, United States, 37232|